Trial progress
How far we’ve come
Recruitment and site activation are key indicators of the trial’s progress. This monthly update shares current enrolment rates by both country and site. Explore how the collective efforts of the REVIVE team are driving steady progress toward enrolment targets and bringing us closer to understanding azithromycin’s role in AHD.
Key trial metrics
Track the latest progress of the REVIVE trial with key recruitment metrics. Data is refreshed Monthly.
Total participants randomised
Countries involved
Active clinical sites
Recent randomisations (last 30 days)
Last updated date
2026-08-19
Country and site profiles
Access detailed country and site profiles from activated REVIVE Trial countries
Africa
How to use the map
Start by clicking a country to see detailed site information
Recruitment by site
Dive into site-specific recruitment data to track performance and monitor progress. Use filters to sort by country, city, or site name.
Last updated date
19/08/2026
Weekly randomisation trends
Stay updated on randomisation trends over time, with data refreshed weekly. Use the interactive chart below to explore enrolment progress.
Recruitment Projection
This graph depicts the projected and actual cumulative participant enrolment for the trial from May 2023 to December 2027
